A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation
Conclusions:
HepatoPredict outperforms conventional clinical-pathologic selection criteria (Milan, UCSF), providing superior prognostic information. Accurately identifying which patients most likely benefit from LT enables an objective stratification of waiting lists and information-based allocation of optimal versus suboptimal organs.
Source: Annals of Surgery - Category: Surgery Tags: ESA Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Hepatocellular Carcinoma | Learning | Liver | Liver Cancer | Liver Transplant | Surgery | Transplants | Universities & Medical Training | Urology & Nephrology